Citrate-based acid concentrate for dialysis: 0.8 mmol/L citric acid and 0.3 mmol/L acetate (vs. 3 mmol/L acetate in standard concentrates). Citrate’s anticoagulant properties improve biocompatibility, reduce hypotension, and lower heparin use.